Please use this identifier to cite or link to this item:
https://doi.org/10.1186/s12876-020-01552-0
Title: | Extraction of intra-biliary hepatocellular carcinoma by endoscopic retrograde cholangiopancreatography | Authors: | Koo, C.S. Ho, K.Y. Pang, Y.H. Huang, D.Q. |
Keywords: | Case report Endoscopic retrograde cholangiopancreatography Hepatocellular carcinoma Intrabiliary Intraductal |
Issue Date: | 2020 | Publisher: | BioMed Central Ltd | Citation: | Koo, C.S., Ho, K.Y., Pang, Y.H., Huang, D.Q. (2020). Extraction of intra-biliary hepatocellular carcinoma by endoscopic retrograde cholangiopancreatography. BMC Gastroenterology 20 (1) : 408. ScholarBank@NUS Repository. https://doi.org/10.1186/s12876-020-01552-0 | Rights: | Attribution 4.0 International | Abstract: | Background: Hepatocellular carcinoma with biliary ductal invasion is rare and associated with a significantly lower survival rate. Case presentation: We present an unusual case of a patient with hepatocellular carcinoma and biliary invasion, who had his diagnosis confirmed by histological analysis from tissue extracted by endoscopic retrograde cholangiopancreatography. An 87-year-old male presented with a 1-day history of right upper quadrant pain and jaundice. His past medical history included recurrent gallstone cholangitis and a previous cholecystectomy. An abdominal CT demonstrated a dilated intrahepatic biliary tree with left proximal intrahepatic hyperdensities, as well as a 3 cm hepatocellular carcinoma. He was initially suspected to have concurrent gallstone cholangitis and a newly diagnosed hepatocellular carcinoma. Endoscopic retrograde cholangiopancreatography and balloon trawling of the intraductal lesions extracted necrotic tumour-like tissue which was histologically consistent with hepatocellular carcinoma. The extraction of the intra-biliary portion of HCC resulted in complete resolution of his jaundice, enabling further treatment with nivolumab, which would not have been possible if the obstruction was not cleared. The patient is currently well and has completed his 6th cycle of nivolumab. Conclusion: Obstructive jaundice is an uncommon presentation for patients with HCC. it is key for clinicians to be aware of the possibility of intrabiliary invasion in order obtain an early diagnosis and to reduce any delay in treatment. © 2020, The Author(s). | Source Title: | BMC Gastroenterology | URI: | https://scholarbank.nus.edu.sg/handle/10635/199253 | ISSN: | 1471230X | DOI: | 10.1186/s12876-020-01552-0 | Rights: | Attribution 4.0 International |
Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1186_s12876_020_01552_0.pdf | 1.35 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License